Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00467766 · ClinicalTrials.gov registry record · NA
Combining a Caregiver Intervention With Aricept Treatment for Mild to Moderate Alzheimer's Disease
A NA study, sponsored by Pfizer.
- Completed
- Registry status
- NA
- Development phase
- 300
- Enrollment target
NCT00467766 is a NA study that has completed, run by Pfizer. The registered enrollment target is 300 participants.
The verdict
NCT00467766, a NA study, has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- NA
- Development phase
- 300 participants
- Enrollment target
Study Summary
A unique multinational study was conducted simultaneously in the USA, England and Australia. The goals of the study were to answer two questions: Does psychosocial support for the family enhance the effectiveness of drug treatment for Alzheimer's disease? Is the added value of psychosocial support the same in all 3 countries?
Interventions
- BEHAVIORAL Psychosocial information, counseling, and support
- DRUG Donepezil (Aricept)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 1999-07 |
| Est. Completion | 2003-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00467766
The ClinicalTrials.gov registry entry for NCT00467766 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Psychosocial information, counseling, and support is the first listed.
NCT00467766 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00467766 about?
NCT00467766 is a clinical study titled "Combining a Caregiver Intervention With Aricept Treatment for Mild to Moderate Alzheimer's Disease". A unique multinational study was conducted simultaneously in the USA, England and Australia. The goals of the study were to answer two questions: Does psychosocial support for the family enhance the effectiveness of drug treatment for Alzheimer's disease? Is the added value of psychosocial support t...
What is the current status of trial NCT00467766?
This trial is currently completed. It is a NA study. The enrollment target is 300 participants. The study started on 1999-07. Estimated completion is 2003-06.
What interventions are being tested in trial NCT00467766?
The interventions under investigation include: Psychosocial information, counseling, and support (BEHAVIORAL), Donepezil (Aricept) (DRUG).
Who is sponsoring clinical trial NCT00467766?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.